Milestones in Skin Carcinogenesis: The Biology of Multistage Carcinogenesis

Journal of Investigative Dermatology

Volumn 134, Issue , 2014, Pages E2-E7

  Balmain, Allan ^a   Yuspa, Stuart H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL; CARCINOGENESIS; HUMAN; METABOLISM; MUTATION; ONCOGENE RAS; PAPILLOMA; SKIN NEOPLASMS;

ANIMALS; CARCINOGENESIS; DNA; GENES, RAS; HUMANS; MUTATION; PAPILLOMA; SKIN NEOPLASMS;

EID: 84921947522     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/skinbio.2014.2     Document Type: Article

References (54)

1. Agrawal, N., Frederick, M.J., Pickering, C.R., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333 (2011), 1154–1157.
2. Bailleul, B., Surani, M.A., White, S., et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter Cell 62 (1990), 697–708.
3. Balmain, A., Pragnell, I.B., Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene Nature 303 (1983), 72–74.
4. Balmain, A., Ramsden, M., Bowden, G.T., et al., Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas Nature 307 (1984), 658–660.
5. Bates, R.R., Ande, Del, Eaton, S., Morgan, D.L., Replication of DNA after binding of the carcinogen 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 45 (1970), 1223–1228.
6. Berenblum, I., Some recent advances in skin carcinogenesis. Ann R Coll Surg Engl 21 (1957), 339–357.
7. Berenblum, I., Haran, N., The significance of the sequence of initiating and promoting actions in the process of skin carcinogenesis in the mouse. Br J Cancer 9 (1955), 268–271.
8. Berenblum, I., Shubik, P., A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br J Cancer 1 (1947), 383–391.
9. Berenblum, I., Shubik, P., The persistence of latent tumor cells induced in the mouse's skin by a single application of 9,10-dimethyl-1,2-benzanthracene Br J Cancer 3 (1949), 384–386.
10. Bizub, D., Wood, A.W., Skalka, A.M., Mutagen-esis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci USA 83 (1986), 6048–6052.
11. Brookes, P., Lawley, P.D., Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic hydrocarbons to deoxyribonucleic acid. Nature 202 (1964), 781–784.
12. Brown, J.R., Thornton, J.L., Percivall Pott (1714-1788) and Chimney Sweepers Cancer of the Scrotum. British J Ind Med 14 (1957), 68–70.
13. Brown, K., Buchmann, A., Balmain, A., Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumour progression. Proc Natl Acad Sci USA 87 (1990), 538–542.
14. Brown, K., Quintanilla, M., Ramsden, M., et al. The viral ras genes of Harvey- and Balbmurine sarcoma viruses can act as initiators of two stage mouse skin carcinogenesis. Cell 46 (1986), 447–456.
15. Brown, K., Strathdee, D., Bryson, S., et al., The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr Biol 8 (1998), 516–524.
16. Castagna, M., Takai, Y., Kaibuchi, K., et al. Direct activation of calcium-activated, phospho-lipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257 (1982), 7847–7851.
17. Cotsarelis, G., Sun, T.T., Lavker, R.M., Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61 (1990), 1329–1337.
18. Delclos, K.B., Nagle, D.S., Blumberg, P.M., Specific binding of phorbol ester tumor promoters to mouse skin. Cell 19 (1980), 1025–1032.
19. Dipple, A., Pigott, M., Moschel, R.C., et al., Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res 43 (1983), 4132–4135.
20. Dunphy, W.G., Delclos, K.B., Blumberg, P.M., Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain. Cancer Res 40 (1980), 3635–3641.
21. Friedewald, W.F., Rous, P., The initiating and promoting elements in tumor production: an analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin. J Exp Med 80 (1944), 101–126.
22. Greenhalgh, D.A., Rothnagel, J.A., Quintanilla, M.I., et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol Carcinog 7 (1993), 99–110.
23. Griner, E.M., Kazanietz, M.G., Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7 (2007), 281–294.
24. Grover, P.L., Hewer, A., Pal, K., et al. The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin. Intl J Cancer 18 (1976), 1–6.
25. Hecker, E., Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res 28 (1968), 2338–2349.
26. Hennings, H., Shores, R., Mitchell, P., et al. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6 (1985), 1607–1610.
27. Iball, J., The relative potency of carcinogenic compounds. Am J Cancer 35 (1939), 188–190.
28. Kemp, C.J., Donehower, L.A., Bradley, A., et al. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumours. Cell 74 (1993), 813–822.
29. Kennaway, E., The identification of a carcinogenic compound in coal-tar. Br Med J 2 (1955), 749–752.
30. Kilkenny, A.E., Morgan, D., Spangler, E.F., et al. Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes. Cancer Res 45 (1985), 2219–2225.
31. Levin, W., Wood, A., Chang, R., et al. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. DrugMetab Rev 13 (1982), 555–580.
32. Marshall, C.J., Vousden, K.H., Phillips, D.H., Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature 310 (1984), 586–589.
33. Morris, R.J., Tryson, K.A., Wu, K.Q., Evidence That the Epidermal Targets of Carcinogen Action Are Found in the Interfollicular Epidermis or Infundibulum as well as in the Hair Follicles. Cancer Res 60 (2000), 226–229.
34. Mottram, J.C., A developing factor in experimental blastogenesis. J Pathol Bacteriol 56 (1944), 181–187.
35. Mottram, J.C., A sensitizing factor in experimental blastogenesis. J Pathol Bacteriol 56 (1944), 391–402.
36. Nagase, H., Bryson, S., Cordell, H., et al. Distinct genetic loci control development of benign and malignant skin tumours. Nat Genet 10 (1995), 424–429.
37. Parada, L.F., Tabin, C.J., Shih, C., et al., Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297 (1982), 474–478.
38. Perucho, M., Goldfarb, M., Shimizu, K., et al. Human-tumor-derived cell lines contain common and different transforming genes. ell 27:3 Pt 2 (1981), 467–476.
39. H gene during mouse skin carcinogenesis Nature 322 (1986), 78–80.
40. Roop, D.R., Lowy, D.R., Tambourin, P.E., et al., An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue Nature 323 (1986), 822–824.
41. Santos, E., Tronick, S.R., Aaronson, S.A., et al., T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes Nature 298 (1982), 343–347.
42. Shih, C., Shilo, B.Z., Goldfarb, M.P., et al., Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin Proc Natl Acad Sci USA 76 (1979), 5714–5718.
43. Shilo, B.Z., Weinberg, R.A., Unique transforming gene in carcinogen-transformed mouse cells. Nature 289 (1981), 607–609.
44. Slaga, T.J., Gleason, G.L., DiGiovanni, J., et al. Potent tumor-initiating activity of the 3,4-di-hydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin Cancer Res 39 (1979), 1934–1936.
45. Sukumar, S., Notario, V., Martin-Zanca, D., et al. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations Nature 306 (1983), 658–661.
46. Taparowsky, E., Suard, Y., Fasano, O., et al., Activation of the T24 bladder carcinoma trans-forming gene is linked to a single amino acid change. Nature 300 (1982), 762–765.
47. The Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers Nature 489 (2012), 519–525.
48. Van Duuren, B.L., Orris, L., The tumor-enhancing principles of Croton tiglium. L. Cancer Res 25 (1965), 1871–1875.
49. Wakabayashi, Y., Mao, J.H., Brown, K., et al., Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445 (2007), 761–765.
50. Wang, N.J., Sanborn, Z., Arnett, K.L., et al., Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 108 (2011), 17761–17766.
51. Yamagiwa, K., Ichikawa, K., Experimental study of the pathogenesis of carcinoma. J Cancer Res 27 (1918), 123–181.
52. Yuspa, S.H., Ben, T., Hennings, H., et al., Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetra-decanoylphorbol-13-acetate. Cancer Res 42 (1982), 2344–2349.
53. Yuspa, S.H., Morgan, D., Lichti, U., et al. Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis 7 (1986), 949–958.
54. Yuspa, S.H., Morgan, D.L., Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 293 (1981), 72–74.